NCT00215800View on ClinicalTrials.gov

The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Chronic Fatigue SyndromeMyalgic Encephalomyelitis
Interventions
DRUG

Ampligen

Sponsors
All Listed Sponsors
lead

AIM ImmunoTech Inc.

INDUSTRY